Experimental stent graft for aortic tear tested in single patient
NCT ID NCT03322033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tested a stent graft device to repair a tear in the ascending aorta (aortic dissection) without open surgery. Only one patient was enrolled, and the study was terminated early. The main goal was to see if patients survived 30 days after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Medtronic Valiant PS-IDE Stent Graft System
- What this could lead to
- If successful, this approach could offer a less invasive treatment option for ascending aortic dissection, potentially reducing recovery time and surgical risks.
- What could go wrong
- This was a very early feasibility study with only 1 participant and was terminated early, so results are extremely limited. The procedure carries risks such as bleeding, stroke, or device failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISSECTION OF THORACIC AORTA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Scott & White The Heart Hospital
Plano, Texas, 75035, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.